Can we use Bone Turnover Markers as Targets for Antiresorptive Treatment in Postmenopausal Osteoporosis? An Analysis from the DECIDE and STAND Clinical Trials

Brown Jacques; Dakin Paula; Hadji Peyman; McClung Michael; Miller Paul; Reginster Jean-Yves; Wagman Rachel; Wang Andrea; McCloskey Eugene

首页> 外文期刊>The Journal of rheumatology >Can we use Bone Turnover Markers as Targets for Antiresorptive Treatment in Postmenopausal Osteoporosis? An Analysis from the DECIDE and STAND Clinical Trials

【24h】

Can we use Bone Turnover Markers as Targets for Antiresorptive Treatment in Postmenopausal Osteoporosis? An Analysis from the DECIDE and STAND Clinical Trials

机译：在绝经后骨质疏松症中，我们可以使用骨转换标志物作为抗吸收治疗的目标吗？ DECIDE和STAND临床试验的分析

获取原文

获取原文并翻译 | 示例

掌桥外文数据库（机构版） >>

开具论文收录证明 >>

文献代查 >>

页面导航

著录项
相似文献
相关主题

著录项

来源
《The Journal of rheumatology》 |2016年第6期|共2页
作者
Brown Jacques; Dakin Paula; Hadji Peyman; McClung Michael; Miller Paul; Reginster Jean-Yves; Wagman Rachel; Wang Andrea; McCloskey Eugene;
展开▼
作者单位

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类免疫性疾病;
关键词

相似文献

外文文献
中文文献
专利

1. Can we use Bone Turnover Markers as Targets for Antiresorptive Treatment in Postmenopausal Osteoporosis? An Analysis from the DECIDE and STAND Clinical Trials [J] . Brown Jacques, Dakin Paula, Hadji Peyman, The Journal of rheumatology . 2016,第6期

机译：在绝经后骨质疏松症中，我们可以使用骨转换标志物作为抗吸收治疗的目标吗？ DECIDE和STAND临床试验的分析
2. Quantitative prediction of bone mineral density by using bone turnover markers in response to antiresorptive agents in postmenopausal osteoporosis: A model-based meta-analysis [J] . Wu Junyi, Wang Chen, Li Guo-Fu, British Journal of Clinical Pharmacology . 2021,第3期

机译：用骨质周转标记用骨质骨质骨质标记对绝经后骨质疏松症的抗血换试剂进行定量预测：基于模型的Meta分析
3. Early Changes in Biochemical Markers of Bone Turnover Predict Bone Mineral Density Response to Antiresorptive Therapy in Korean Postmenopausal Women with Osteoporosis [J] . Sang Wan KIM, Do Joon PARK, Kyong Soo PARK, Endocrine journal . 2005,第6期

机译：骨周转生化指标的早期变化预测骨质疏松症的韩国绝经后妇女对抗吸收疗法的骨矿物质密度反应
4. Antiresorptive effect of denosumab in the treatment of osteoporosis in patients with rheumatoid arthritis [C] . M. A. Korolev, N. E. Banshchikova, E. A. Letjagina, 2017 International Multi-Conference on Engineering, Computer and Information Sciences . 2017

机译：地诺单抗对类风湿关节炎骨质疏松症的抗吸收作用
5. The relationship of vitamin D and selected nutrient intakes, sex hormone binding globulin and markers of bone turnover to bone mineral density in exercising and non-exercising postmenopausal women taking or not taking HRT. [D] . Sparks, Patricia Lynne. 2001

机译：在接受或不接受HRT的运动和非运动绝经后妇女中，维生素D与选定的营养摄入量，性激素结合球蛋白以及骨转换标志与骨矿物质密度的关系。
6. Bone‐Forming and Antiresorptive Effects of Romosozumab in Postmenopausal Women With Osteoporosis: Bone Histomorphometry and Microcomputed Tomography Analysis After 2 and 12 Months of Treatment [O] . Pascale Chavassieux, Roland Chapurlat, Nathalie Portero‐Muzy, -1

机译：Romosozumab在绝经后骨质疏松妇女中的骨形成和抗吸收作用：治疗2个月和12个月后骨组织形态计量学和微计算机断层扫描分析
7. The effect of short-term low-energy ultraviolet B irradiation on bone mineral density and bone turnover markers in postmenopausal women with osteoporosis: A randomized single-blinded controlled clinical trial [O] . Micić Ivan, Jeon In-Ho, Park So-Hyun, 2013

机译：短期低能量紫外线B照射对绝经后骨质疏松症女性骨密度和骨转换指标的影响：一项随机单盲对照临床试验

Can we use Bone Turnover Markers as Targets for Antiresorptive Treatment in Postmenopausal Osteoporosis? An Analysis from the DECIDE and STAND Clinical Trials

著录项

相似文献

相关主题

期刊订阅